Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages

Go back to Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
(NASDAQ: QTRX) Delayed: 2.69 +0.11 (4.26%)
Previous Close $2.58    52 Week High
Open $2.58    52 Week Low
Day High $2.70    P/E N/A 
Day Low $2.54    EPS
Volume 274,591